publication venue for Dual targeting of human epidermal growth factor receptor 2 (HER2) in neoadjuvant trials for operable HER2 positive (HER2+) disease. 5. 2013 The PI3K/AKT/mTOR signaling pathway: Implications in the treatment of breast cancer. 3. 2011
